Early detection of cancer: ideas for a debate.

[1]  J. Wardle,et al.  Can cancer risk information raise awareness without increasing anxiety? A randomized trial. , 2006, Preventive medicine.

[2]  W. Black.  Randomized clinical trials for cancer screening: rationale and design considerations for imaging tests. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  L. Solberg,et al.  Colorectal cancer screening: health impact and cost effectiveness. , 2006, American journal of preventive medicine.

[4]  Y. Lotan,et al.  Economic impact of screening for bladder cancer using bladder tumor markers: a decision analysis. , 2006, Urologic oncology.

[5]  J. Melia.  Part 1: The burden of prostate cancer, its natural history, information on the outcome of screening and estimates of ad hoc screening with particular reference to England and Wales , 2005, BJU international.

[6]  R. Postma,et al.  Screening for prostate cancer. , 2003, European journal of cancer.

[7]  Stephen W Duffy,et al.  A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.

[8]  Floyd J Fowler,et al.  Enthusiasm for cancer screening in the United States. , 2004, JAMA.

[9]  T. H. van der Kwast,et al.  Interval carcinomas in the European Randomized Study of Screening for Prostate Cancer (ERSPC)-Rotterdam. , 2003, Journal of the National Cancer Institute.

[10]  A. Feinberg,et al.  Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk , 2003, Science.

[11]  H. Mulcahy,et al.  Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: Time for large‐scale clinical studies? , 2003, International journal of cancer.

[12]  Klaus Jung,et al.  Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies. , 2002, Clinical chemistry.

[13]  A Evans.  Hormone replacement therapy and mammographic screening. , 2002, Clinical radiology.

[14]  James T. Wu,et al.  Cell-free DNA: measurement in various carcinomas and establishment of normal reference range. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[15]  Lisa M. Schwartz,et al.  Risk charts: putting cancer in context. , 2002, Journal of the National Cancer Institute.

[16]  K. Mizumoto,et al.  A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus , 2002, Cancer.

[17]  J. Wardle,et al.  Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial , 2002, The Lancet.

[18]  H. Welch,et al.  COMMENTARY Risk Charts: Putting Cancer in Context , 2002 .

[19]  S. Loening,et al.  Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer. , 2002, Urology.

[20]  S. Moss,et al.  The relation between mortality from malignant melanoma and early detection in the Cancer Research Campaign Mole Watcher Study , 2001, British Journal of Cancer.

[21]  R. Warren,et al.  Screening women at high risk of breast cancer on the basis of evidence. , 2001, European journal of radiology.

[22]  S. Ciatto,et al.  Measuring interval cancers in population‐based screening using different assays of fecal occult blood testing: The district of Florence experience , 2001, International journal of cancer.

[23]  M. Sherman,et al.  Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis , 2001, Gut.

[24]  T. H. van der Kwast,et al.  Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination. , 2001, Urology.

[25]  R Wender,et al.  American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001—Testing for Early Lung Cancer Detection , 2001, CA: a cancer journal for clinicians.

[26]  R. Blanks,et al.  Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality , 2000, BMJ : British Medical Journal.

[27]  S Chevret,et al.  Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death , 2000, Gut.

[28]  S. Moss,et al.  Feasibility of targeted early detection for melanoma: a population-based screening study , 2000, British Journal of Cancer.

[29]  L. Rutqvist,et al.  Radiation risk and mammographic screening of women from 40 to 49 years of age: effect on breast cancer rates and years of life , 1999, British Journal of Cancer.

[30]  K. Kopecky,et al.  An initial experience with screening for colon polyps using spiral CT with and without CT colography (virtual colonoscopy) , 1999, Gastrointestinal endoscopy.

[31]  C. Johnson,et al.  Screening by CT colonography: too early to pass judgment on a nascent technology. , 1999, Gastrointestinal endoscopy.

[32]  Osborne,et al.  The effect of the introduction of a pigmented lesion clinic on the interval between referral by family practitioner and attendance at hospital , 1998, The British journal of dermatology.

[33]  C J Baines,et al.  The Gothenburg breast screening trial , 1997, Cancer.

[34]  J. Henritze,et al.  Coorscreen: A Low-Cost, on-Site Mammography Screening Program , 1996, American journal of health promotion : AJHP.

[35]  J Benichou,et al.  Graphs to estimate an individualized risk of breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  A. Miller,et al.  Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. , 1995, Journal of the National Cancer Institute.

[37]  D. Whynes,et al.  Screening and the costs of treating colorectal cancer. , 1993, British Journal of Cancer.

[38]  L. Kiemeney,et al.  General practitioners' workload after skin cancer/melanoma screening clinics in The Netherlands. , 1993, Dermatology.

[39]  W. Willett,et al.  Breast cancer (2). , 1992, The New England journal of medicine.

[40]  M. S. Blois,et al.  Patient and physician delay in melanoma diagnosis. , 1988, Journal of the American Academy of Dermatology.